发明名称 |
DNA CODING HUMAN INTERLEUKIN 1ALPHA POLYPEPTIDE |
摘要 |
PURPOSE:To obtain a surface DNA useful for production of treating agent for immunodeficiency or tuner by isolating a clones DNA coding human interleukin 1 precursor polypeptide using a human HL-60 cell and then subjecting the isolated cloned DNA to restriction enzyme treatment. CONSTITUTION:A human acute myeloid leukemia strain cell (human HL-60 cell) is cultured in a culture medium containing a differentiation inducing agent and a cell differentiated from the cultured mixture is collected and treated with a inducing agent such as enditoxin and then RNA is extracted by an ordinary method and subjected to oligo(dT)cellulose column to separate mRNA. Cyclic DNA is synthesized using this mRNA as a template and the cDNA is subjected to restriction enzyme treatment, bound to a vector and introduced into a host to prepare cDNA library, which is then cultured and is subjected to cloning using a gene fragment coding interleukin 1 as a probe to select positive clone. A plasmid is extracted from the clone and then subjected to restriction enzyme treatment to produce DNA coding a human interleukin 1alpha polypeptide expressed by the formula. |
申请公布号 |
JPH04330282(A) |
申请公布日期 |
1992.11.18 |
申请号 |
JP19910124909 |
申请日期 |
1991.04.25 |
申请人 |
DAINIPPON PHARMACEUT CO LTD |
发明人 |
YAMADA MASAAKI;FURUYA TAIJI;YAMAYOSHI MICHIKO;NOTAKE MITSUE;YAMAGISHI JUNICHI |
分类号 |
A61K35/12;A61K35/74;A61K38/00;A61P35/00;C07K14/00;C07K14/52;C07K14/54;C07K14/545;C12N1/21;C12N15/09;C12N15/25;C12N15/71;C12P21/02;C12R1/19 |
主分类号 |
A61K35/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|